Robotic surgical systems such as teleoperative systems are used to perform minimally invasive surgical procedures that offer many benefits over traditional open surgery techniques, including less pain, shorter hospital stays, quicker return to normal activities, minimal scarring, reduced recovery time, and less injury to tissue.
Robotic surgical systems can have a number of robotic arms that move attached instruments or tools, such as an image capturing device, a stapler, an electrosurgical instrument, etc., in response to movement of input devices by a surgeon viewing images captured by the image capturing device of a surgical site. During a robotic surgical procedure, each of the tools is inserted through an opening, either natural or an incision, into the patient and positioned to manipulate tissue at a surgical site. The openings are placed about the patient's body so that the surgical instruments may be used to cooperatively perform a robotic surgical procedure and the image capturing device may view the surgical site.
During a robotic surgical procedure it is important to accurately know and control the position of the tools within the surgical site. Accordingly, there is a continuing need for systems and methods for detecting and controlling the position of tools within a surgical site during robotic surgical procedures.
This disclosure relates controlling a surgical robot from visually capturing a tool pose within a surgical site. In disclosed methods, an imaging device captures a tool pose of a tool within a surgical site. The surgical robot then determines an arm pose of a linkage supporting the tool. The surgical robot then manipulates the arm to move the tool to a desired tool pose in response to input from a clinician. Visually determining the tool pose provides improved accuracy and resolution to the position of the tool within the surgical site. The improved accuracy and resolution can be used to complete precision movements and may assist in completing automated actions. Visually determining the tool pose also eliminates discrepancies in kinematic models that are induced by loads and dynamic performance of joints.
In some methods disclosed herein functions of tools are enabled and disabled based on a visually captured tool pose. The function of the tool can be enabled as the end effector of the tool is within an enabled zone of the surgical site. The enabled zone can be determined based on the location of targeted tissue, the size of targeted tissue, the proximity of nontargeted tissue relative to targeted tissue, or the type of function of the tool. The surgical robot can be controlled by a user interface which includes a display. The display shows a graphical representation of the surgical site and can provide visual indicia of the enabled zone and the enabled/disabled status of the function of the tool. For example, the display can have a border that shows one color when the function of the tool is enabled and another color when the function of the tool is disabled. Additionally or alternatively, the display can show the tool in one color when the function of the tool is enabled and show the tool in another color when the function of the tool is disabled. It is contemplated that when the tool is in the enabled zone, the surgical robot can complete automated tasks within the surgical site with the tool. In particular methods, the user interface can track the gaze of the clinician to verify that the clinician's gaze is focused or directed to a representation of the enabled zone on the display before enabling the function of the tool. It is contemplated that by requiring a tool to be within the enabled zone and/or that the clinician's gaze is directed to the enabled zone before activating a function of the tool can increase safety during a robotic surgical procedure by reducing inadvertent or unintended activations of tool functions when the tool is outside of an enabled zone.
In certain methods, a center of view of an imaging device can automatically track a centroid during a surgical procedure. The tracked centroid can be a centroid of a tool, a point between a centroid of a tool and targeted tissue, or a point between centroids of multiple tools. The tracked centroid can be automatically assigned to active tools within the surgical site or can be selectively assigned by the clinician. By automatically tracking a centroid during a surgical procedure, a clinician can concentrate on the procedure without having to focus on moving the imaging device. The method may include receiving the control signal from a user interface of a robotic surgical system.
In an aspect of the present disclosure, a method of controlling a surgical robot includes visually capturing a first tool pose of a first tool within a surgical site in a fixed frame of reference with an imagining device, determining a first arm pose of a first linkage supporting the first tool from known geometries of the first linkage in the fixed frame of reference, and manipulating the first linkage to move the first tool to a desired first tool pose in the fixed frame of reference in response to a first control signal.
In aspects, visually capturing the first tool pose of the first tool in the fixed frame of reference includes defining the fixed frame of reference in a frame defined by the imaging device. Visually capturing the first tool pose of the first tool in the fixed frame of reference may include capturing the first tool pose with both a first lens and a second lens of the imaging device.
In some aspects, visually capturing the first tool pose includes identifying the position of one or more markers on the first tool. Visually capturing the first tool pose may include capturing the position of the one or more markers within an infrared spectrum of light.
In certain aspects, the method includes visually capturing a second tool pose of a second tool within the surgical site in the fixed frame of reference with the imaging device, determining a second arm pose of a second linkage supporting the second tool from known geometries of the second linkage in the fixed frame of reference, and manipulating the second linkage to move the second tool to a desired second tool pose in the fixed frame of reference in response to a second control signal. Determining the first arm pose and determining the second arm pose may occur entirely within the fixed frame of reference.
In another aspect of the present disclosure, a method of controlling a function of a tool of a surgical system including capturing images of a surgical site with an imaging device, determining a distance of the tool within the surgical site relative to targeted tissue, enabling activation of a function of the tool when the tool is within a predetermined distance from the targeted tissue, and activating the function of the tool to manipulate the tool in response to a control signal.
In aspects, the enabling activation of the function of the tool includes providing visual indicia to a clinic engaged with the surgical system that the function is enabled. Providing visual indicia may include changing a color of a border of a display of the surgical system.
In some aspects, the method may include disabling activation of the function of the tool when the tool is beyond the predetermined distance from the targeted tissue. Disabling activation of the function may include providing visual indicia to a clinician engaged with the surgical system that the function is disabled. Providing visual indicia may include changing a color of a border of a display of the surgical system.
In certain aspects, the method may include the surgical system completing an automated task within the surgical site with the tool when the tool is within the predetermined distance from the target tissue. Completing the automated task may include suturing the targeted tissue when the tool is within the predetermined distance from the targeted tissue.
In particular aspects, the method may include verifying that a gaze of a clinician interfacing with the surgical system is directed to an enabled zone on a display of the surgical system before enabling activation of the function of the tool. Activating the function of the tool to manipulate tissue with the tool may include at least one of clamping tissue with the tool, delivering electrosurgical energy to tissue with the tool, stapling tissue with the tool, suturing tissue with the tool, or advancing a cutting edge or knife of the tool through tissue.
In another aspect of the present disclosure, a surgical system includes an imaging device, a tool, and a processing unit. The imaging device is configured to capture images of a surgical site. The tool has a function that is configured to manipulate tissue in response to a control signal. The processing unit is in communication with the imaging device and the tool and is configured to determine a distance of the tool relative to targeted tissue from the captured images and enable activation of the function of the tool when the tool is positioned within a predetermined distance of the targeted tissue.
In aspects, the surgical system includes a display that is configured to provide a representation of the surgical site. The processing unit may be configured to provide a representation of an enablement zone defined by the predetermined distance within the representation of the surgical site. The processing unit may be configured to provide visual indicia on the display when the function of the tool is enabled. The display may be configured to change a color of a border of the display when the function of the tool is enabled.
In some aspects, the surgical system includes a display that is configured to provide a representation of the surgical site. The processing unit may be configured to verify that a gaze of a clinician is directed to the display before enabling activation of the function of the tool. The processing unit may be configured to complete an automated task when the tool is within the predetermined distance of the targeted tissue. The processing unit may be configured to prevent activation of the function of the tool when the tool is positioned beyond the predetermined distance from the targeted tissue.
In another aspect of the present disclosure, a method of manipulating an imaging device includes identifying a tracked centroid within a field of view of the imaging device, manipulating a pose of the imaging device to posing the tracked centroid at a center of the field of view of the imaging device, moving a first tool within the field of view such that the tracked centroid is moved within the field of view of the imaging device, and tracking the tracked centroid as the first tool is moved within the field of view and maintaining the tracked centroid at the center of the field of view of the imaging device.
In aspects, identifying the tracked centroid includes defining the tracked centroid as a first tool centroid of the first tool. Alternatively, identifying the tracked centroid may include defining the tracked centroid as a point between a first tool centroid of the first tool and targeted tissue. The tracked centroid may be a midpoint of a line between the first tool centroid and a centroid of the targeted tissue.
In some aspects, the method includes moving a second tool within the field of view such that the tracked centroid is moved within the field of view of the imaging device. Identifying the tracked centroid may include defining the tracked centroid as appoint between a first tool centroid of the first tool and a second tool centroid of the second tool. The tracked centroid may be a midpoint of a line between the first tool centroid and the second tool centroid. Alternatively, identifying the tracked centroid may include defining the tracked centroid as a point triangulated between a first tool centroid of the first tool, a second tool centroid of the second tool, and targeted tissue.
In certain aspects, manipulating the pose of the imaging device includes moving an arm of a surgical robot supporting the imaging device. Tracking the tracked centroid may include delaying reentering of the field of view of the imaging device until the tracked centroid is misaligned a predetermined distance from the center of the field of view. Tracking the tracked centroid may include limiting a velocity of movement of the field of view of the imaging device.
In another aspect of the present disclosure, a surgical system includes a first tool, an arm, and an imaging device. The first tool is at least partially defines a tracked centroid. The arm is movable within a surgical site. The imaging device is supported on the arm and has a field of view. The imaging device is configured to be manipulated to maintain the tracked centroid at a center of the field of view.
In aspects, the tracked centroid is defined at a first tool centroid of the first tool. Alternatively, the tracked centroid may be defined at a point between a first tool centroid of the first tool and a target within the surgical site.
In some aspects, the surgical system includes a second tool. The tracked centroid may be defined at a point between a first tool centroid of the first tool and a second tool centroid of the second tool. The tracked centroid may be triangulated at a point between a first tool centroid of the first tool, a second tool centroid of the second tool, and a target within the surgical site.
It is envisioned that the methods herein can be implemented in the software of existing robotic surgical systems to improve the efficacy of the existing system. In addition, some of the methods detailed herein can be enhanced with specialized equipment.
Further, to the extent consistent, any of the aspects described herein may be used in conjunction with any or all of the other aspects described herein.
Various aspects of the present disclosure are described hereinbelow with reference to the drawings, which are incorporated in and constitute a part of this specification, wherein:
Embodiments of the present disclosure are now described in detail with reference to the drawings in which like reference numerals designate identical or corresponding elements in each of the several views. As used herein, the term “clinician” refers to a doctor, a nurse, or any other care provider and may include support personnel. Throughout this description, the term “proximal” refers to the portion of the device or component thereof that is closest to the clinician or surgical robot arm and the term “distal” refers to the portion of the device or component thereof that is farthest from the clinician or surgical robot arm.
Referring to
The user interface 40 includes a display device 44 which is configured to display three-dimensional images. The display device 44 displays three-dimensional images of the surgical site “S” which may include data captured by imaging devices 16 positioned on the ends 14 of the arms 12 and/or include data captured by imaging devices that are positioned about the surgical theater (e.g., an imaging device positioned within the surgical site “S”, an imaging device positioned adjacent the patient, imaging device 56 positioned at a distal end of an imaging linkage or arm 52). The imaging devices (e.g., imaging devices 16, 56) may capture visual images, infra-red images, ultrasound images, X-ray images, thermal images, and/or any other known real-time images of the surgical site “S”. The imaging devices transmit captured imaging data to the processing unit 30 which creates three-dimensional images of the surgical site “S” in real-time from the imaging data and transmits the three-dimensional images to the display device 44 for display.
The user interface 40 also includes input handles 42 which are supported on control arms 43 which allow a clinician to manipulate the robotic system 10 (e.g., move the arms 12, the ends 14 of the arms 12, and/or the tools 20). Each of the input handles 42 is in communication with the processing unit 30 to transmit control signals thereto and to receive feedback signals therefrom. Additionally or alternatively, each of the input handles 42 may include input devices (not shown) which allow the surgeon to manipulate (e.g., clamp, grasp, fire, open, close, rotate, thrust, slice, etc.) the end effectors 22 of the tools 20 supported at the ends 14 of the arms 12.
Each of the input handles 42 is movable through a predefined workspace to move the ends 14 of the arms 12 within a surgical site “S”. The three-dimensional images on the display device 44 are orientated such that movement of the input handle 42 moves the ends 14 of the arms 12 as viewed on the display device 44. It will be appreciated that the orientation of the three-dimensional images on the display device may be mirrored or rotated relative to view from above the patient. In addition, it will be appreciated that the size of the three-dimensional images on the display device 44 may be scaled to be larger or smaller than the actual structures of the surgical site “S” permitting a clinician to have a better view of structures within the surgical site “S”. As the input handles 42 are moved, the tools 20, and thus the end effectors 22, are moved within the surgical site “S” as detailed below. As detailed herein, movement of the tools 20 may also include movement of the ends 14 of the arms 12 which support the tools 20.
For a detailed discussion of the construction and operation of a robotic surgical system 1, reference may be made to U.S. Pat. No. 8,828,023, the entire contents of which are incorporated herein by reference.
With reference to
The first link 110 has a first end 110a and a second end 110b. The first end 110a is rotatably coupled to a fixed structure. The fixed structure can be a movable cart 102 locked in position, a surgical table, a stanchion, an operating room wall, or other structure present in the operating room. A first motor “M1” is operably coupled to first end 110a to rotate the first link 110 about a first axis of rotation A1 that passes through the first end 110a transverse to a longitudinal axis of the first link 110. The second end 110b of first link 110 has a second motor “M2” operably coupled to a first end of 120a of the second link 120 such that actuation of motor “M2” effects a rotation of the second link 120 relative to first link 110 about a second axis of rotation A2 defined through the second end 110b of first link 110 and a first end 120a of second link 120. It is envisioned the second axis of rotation A2 can be transverse to the longitudinal axis of the first link 110 and a longitudinal axis of the second link 120.
A second end 120b of the second link 120 is operably coupled to the first end 130a of the third link 130 such that the third link 130 rotates relative to the second link 120 about a third axis of rotation A3 that passes through the second end 120b of the second link and the first end 130a of the third link 130. The third axis of rotation A3 is parallel to the second axis of rotation A2. Rotation of the second link 120 about the second axis of rotation A2 affects rotation of the third link 130 about the third axis of rotation A3 such that the first and third links 110, 130 maintain a substantially parallel relationship with one another. For a detailed description of exemplary mechanisms to maintain the substantially parallel relationship between the first and third links, reference may be made to U.S. Provisional Patent Application No. 62/615,578, filed Jan. 10, 2018, and entitled “SURGICAL ROBOTIC ARMS AND PULLEY ASSEMBLIES THEREOF” and PCT Patent Application No. PCT/US2019/12839, filed Jan. 9, 2019, and entitled “SURGICAL ROBOTIC ARMS AND PULLEY ASSEMBLIES THEREOF,” the entire contents of which are incorporated herein by reference.
A second end 130b of the third link 130 is operably coupled to a first end 140a of the fourth link 140. The fourth link 140 is rotatable relative to the third link 130 about a fourth axis of rotation A4 that passes through the second end 130b of the third link 130 and the first end 140a of the fourth link 140.
With additional reference to
During a surgical procedure, the robotic system 10 receives input commands from the user interface 40 to move the tool 20 such that the end effector 22 is moved to manipulate and/or act on tissue within the surgical site “S”. Specifically, the links 110, 120, 130, 140 of the robot arm 12 are rotated relative to one another and the slider 142 is translated to position and orientate the tool 20 within the surgical site “S” in response to the input commands. To control the robot arm 12, the robotic system 10 calculates a desired tool pose of the tool 20 from the input commands, captures a tool pose of the tool 20, and manipulates the robot arm 12 to move the tool 20 to the desired tool pose. From the desired tool pose, the robotic system 10 calculates a required arm pose of the robot arm 12 to achieve the desired tool pose. The robot arm 12 then determines which links 110, 120, 130, 140 to manipulate to reach the required arm pose and thus, the desired tool pose of the tool 20 within the surgical site “S” in response to input captured by the user interface 40 (
To determine the arm pose of the robot arm 12, the robot system 10 uses an imaging device or endoscope 200 positioned within the surgical site “S” to capture the position and orientation or tool pose of the tool 20 within the surgical site “5”. As detailed herein below, the endoscope 200 is described as capturing the tool pose within the surgical site; however, it is contemplated that imaging devices can be used and that each one of the imaging devices can include a single or multiple lenses to capture two or three dimensional images.
The endoscope 200 can be stationary within the surgical site “S”, can be manipulated by a clinician within the surgical theater, or can be attached to another robot arm 12 such that the position and orientation of the endoscope 200 can be manipulated during a surgical procedure. The robotic system 10 uses the endoscope 200 to visually capture the tool pose of the tool 20 within the surgical site “S” using known techniques. The tool 20 may include indicia to aid in capturing the tool pose, which may include, but are not limited to, using distinct colors, distinct markings, distinct shapes, or combinations thereof. The tool pose of the tool 20 is captured in a camera frame relative to the endoscope 200 and can be translated to a frame of the surgical site “S”, a frame of the tool 20, a frame of the robot arm 12, or any other desired frame of reference. It is envisioned that it may be beneficial to translate the tool pose of the tool 20 to a fixed frame.
From the tool pose of the tool 20, the robotic system 10 can use known kinematics of the robot arm 12 to calculate an arm pose of the robot arm 12 starting from the tool pose of the tool 20 and working towards the first link 110. By calculating the arm pose of the robot arm 12 from tool pose of the tool 20, a solution to move the tool 20 to a desired tool pose within the surgical site “S” accounts for any deformations of the robot arm 12 or the tool 20 when under load. In addition, by calculating the arm pose from the tool pose, it is unnecessary to know the position of the fixed structure (e.g., movable cart 102), to which the first link 110 (
It is contemplated that the robot system 10 can be used to simultaneously capture the tool pose of multiple tools 20 with the endoscope 200. By capturing the tool pose of multiple tools 20, the interaction of the tools 20 and the end effectors 22 of the tools 20 can be controlled with high precision. This high precision control can be used to complete automated tasks; for example, suturing tissue. It is envisioned that by using a single endoscope 200 to capture the tool poses of multiple tools 20, the speed and accuracy of automated tasks can be increased by reducing the need to translate the high precision tool poses from a camera frame to another frame for the duration of the automated task.
It is contemplated that more than one camera and/or endoscope 200 can be used to simultaneously capture the tool pose of the tool 20 within the surgical site “S”. It will be appreciated that when multiple cameras are used that it may be beneficial to translate the position and orientation of the tool 20 to a frame other than a frame defined by one of the cameras.
It is contemplated that determining the arm pose from the captured tool pose allows for determining the position of movable carts 102 supporting each of the arms 12 from the captured tool pose and the kinematics of the arms 12. After the surgical procedure is completed, the efficiency of the surgical procedure can be determined and the position of the movable carts 102 recorded. By comparing the position of movable carts 102 during surgical procedures with high efficiency ratings, a guide or recommended locations of the movable carts 102 for a given procedure can be provided to increase the efficiency of future surgical procedures. Increased efficiency of surgical procedures can reduce cost, surgical time, and recovery time while improving surgical outcome.
Continuing to refer to
With the targeted tissue “T” identified, an enabled zone “EZ” is created about the targeted tissue “T” such that activation of a function of the tool 20 is limited to when the end effector 22 of the tool 20 is within the enabled zone “EZ”. By limiting activation of the function of the tool 20 to when the end effector 22 is within the enabled zone “EZ” can prevent inadvertent or unintentional activation of the tool 20.
The enabled zone “EZ” is based on geometric locales within the surgical site “S” adjacent the targeted tissue “T”. The size of the enabled zone “EZ” can be based on the function or functions (e.g., clamping, delivery of electrosurgical energy, stapling, suturing, advancement of a knife, etc.) of the tool 20. The enabled zone “EZ” can also be based on the proximity of other anatomical structures to the targeted tissue “T”. For example, when other anatomical structures are spaced apart from the targeted tissue “T” the enabled zone “EZ” may be larger than when other anatomical structures are close to or in contact with the targeted tissue “T”. The enabled zone “EZ” can be set manually before or during the surgical procedure or can be set automatically based on the function of the tool 20. It is contemplated that for a given surgical procedure, targeted tissue “T” can be in more than one location with the surgical site “S”. During such a surgical procedure, the surgical site “S” can include an enabled zone “EZ” about each targeted tissue “T”.
With additional reference to
During the surgical procedure, the tool pose of the tool 20, is captured by the camera as detailed above. When the robotic system 10 determines, from the tool pose, that the end effector 22 is outside of the enabled zone “EZ”, the robotic system 10 prevents a clinician from activating a function of the tool 20. It is contemplated that the display 44 may also provide a visual indication that the function of the tool 20 is disabled. For example, a border 45 on the display 44 may be red in color, the tool 20 or a portion of the tool 20 (e.g., the end effector 22) may be red in color. Additionally or alternatively, an activation button (not shown) on the input handle 42 (
As the robotic system 10 determines, from the tool pose, that the end effector 22 enters the enabled zone “EZ”, the robotic system 10 enables the function of the tool 20. As the tool 20 enters the enabled zone “EZ”, the display 44 may provide a visual indication that the function of the tool 20 is enabled. For example, the border 45 on the display 44 may be green, the tool 20 or a portion of the tool 20 (e.g., the end effector 22) may be green. Additionally or alternatively, an activation button (not shown) on the input handle 42 (
It is envisioned that during a surgical procedure where multiple tools 20 are within the surgical site “S”. The tools 20 may independently enable a function of the tool 20 based on the position of the end effector 22 of the respective tool relative to the enabled zone “EZ” of the targeted tissue “T”. Alternatively, it is contemplated that where multiple tools are within the surgical site “S”, that functions of the tools 20 may only be enabled when both end effectors 22 are positioned within the enabled zone “EZ”. Limiting enablement of the functions in such a manner may be preferred when the tools 20 cooperate together to act on the targeted tissue “T”.
The method may include verifying a gaze of a clinician engaged with the user interface 40 is directed to the enabled zone “EZ” on the display 44 before enabling a function of the tool 20. Specifically, during the surgical procedure, the user interface 40 tracks the gaze of the clinician engaged therewith. As the endoscope 200 determines that the end effector 22 of one of the tools 20 enters the enabled zone “EZ”, the user interface 40 verifies that the gaze of the clinician engaged with the user interface 40 is directed to a portion of the display 44 including a representation of the targeted tissue “T” and/or the enabled zone “EZ”. Requiring the clinician's gaze to be directed to the target tissue “T” or the enabled zone “EZ” before enabling the function of the tool 20 provides an additional level of safety to the surgical procedure.
As detailed above, the endoscope 200 can be movable about the surgical site “S”. It is contemplated that as the endoscope 200 is moved about the surgical site “S” the function of the tool 20 would be disabled until the position of the endoscope 200 is stationary. By disabling the function of the tool 20 as the endoscope 200 is moved about the surgical site “S” provides an additional level of safety to the surgical procedure.
Referring to
The endoscope 200 is disposed on an arm 12 of the robotic system 10 (
With the field and center of view “CV” of the endoscope 200 set, the end effector 22 of the tool 20 is brought within a field of view “FV” the endoscope 200. The endoscope 200 is then used to determine a tool pose of the tool 20 as detailed above. From the tool pose, a centroid “C1” of the end effector 22 can be determined. The center of view of the endoscope 200 is re-centered to be directed to the centroid “C1” of the end effector 22 such that the centroid “C1” is tracked by the endoscope 200. As used herein, it is understood that centroid may include features or the like, or locations that are mathematically computable.
During the surgical procedure it will be appreciated that the centroid “C1” of the end effector 22 is moved about the surgical site “S”. As the centroid “C1” is moved, the center of view “CV” of the endoscope 200 re-centers to track the centroid “C1” of the end effector 22. By re-centering the center of view “CV” of the endoscope 200 during the surgical procedure, the attention and focus of the clinician can be directed to the surgical procedure.
The re-centering can be done in a manner such that the center of view “CV” of the moves in a manner that does not distract a clinician viewing the display 44 (
It is contemplated that, the center of view of the endoscope 200 can track a centroid “C2” which is centered between the centroid “C1” of the end effector 22 and the targeted tissue “T”. In addition, the endoscope 200 can adjust its field of view “FV” based on the distance between the centroid “C1” of the end effector 22 and the targeted tissue “T” such that as the end effector 22 approaches the targeted tissue “T”, the endoscope 200 zooms in or reduces the size of the field of view “FV”. In addition, as the end effector 22 moves away from the targeted tissue “T”, the endoscope 200 zooms out or increased the size of the field of view “FV”.
During surgical procedures with two tools 20 within the surgical site “S”, the center of view “CV” of the endoscope 200 can track a centroid “C4” that is a centered between the centroid “C1” of a first end effector 22 and a centroid “C3” of a second end effector 22. By tracking the centroid “C4” with the center of view “CV” of the endoscope 200, interactions of the first and second end effectors 22 can be viewed by the clinician. In addition, the endoscope 200 can change its field of view “FV” to zoom in and out based on the distance between the centroids “C1” and “C3”. Alternatively, the center of view “CV” of the endoscope 200 can track the centroid “C2” centered between the centroid “C1” of the first end effector 22 and the targeted tissue “T” and disregard the centroid “C3” of the second end effector 22. It will be appreciated that a form of hysteresis may also be introduced to the tracking of the centroid “C4” with the center of view “CV” of the endoscope 200.
During surgical procedures with more than two tools 20 within the surgical site “S”, the center of view “CV” of the endoscope 200 can track a centroid (e.g., centroid “C4”) that is centered between centroids (e.g., centroids “C1” and “C3”) of active end effectors 22 in a manner similar to that detailed above with respect to two tools 20. As the active end effectors 22 change within the surgical site “S”, the center of view “CV” of the endoscope 200 re-centers on a centroid between the active end effectors 22.
While several embodiments of the disclosure have been shown in the drawings, it is not intended that the disclosure be limited thereto, as it is intended that the disclosure be as broad in scope as the art will allow and that the specification be read likewise. Any combination of the above embodiments is also envisioned and is within the scope of the appended claims. Therefore, the above description should not be construed as limiting, but merely as exemplifications of particular embodiments. Those skilled in the art will envision other modifications within the scope of the claims appended hereto.
This application is a National Stage Application of PCT Application Serial No. PCT/US2019/012847 under 35 USC § 371 (a), filed Jan. 9, 2019, which claims benefit of and priority to U.S. Provisional Patent Application Ser. No. 62/615,590 filed Jan. 10, 2018, the disclosures of each of the above-identified applications are hereby incorporated by reference in their entirety.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2019/012847 | 1/9/2019 | WO |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2019/139949 | 7/18/2019 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
6132368 | Cooper | Oct 2000 | A |
6206903 | Ramans | Mar 2001 | B1 |
6246200 | Blumenkranz et al. | Jun 2001 | B1 |
6312435 | Wallace et al. | Nov 2001 | B1 |
6331181 | Tierney et al. | Dec 2001 | B1 |
6394998 | Wallace et al. | May 2002 | B1 |
6424885 | Niemeyer et al. | Jul 2002 | B1 |
6441577 | Blumenkranz et al. | Aug 2002 | B2 |
6459926 | Nowlin et al. | Oct 2002 | B1 |
6491691 | Morley et al. | Dec 2002 | B1 |
6491701 | Tierney et al. | Dec 2002 | B2 |
6493608 | Niemeyer | Dec 2002 | B1 |
6565554 | Niemeyer | May 2003 | B1 |
6645196 | Nixon et al. | Nov 2003 | B1 |
6659939 | Moll | Dec 2003 | B2 |
6671581 | Niemeyer et al. | Dec 2003 | B2 |
6676684 | Morley et al. | Jan 2004 | B1 |
6685698 | Morley et al. | Feb 2004 | B2 |
6699235 | Wallace et al. | Mar 2004 | B2 |
6714839 | Salisbury, Jr. et al. | Mar 2004 | B2 |
6716233 | Whitman | Apr 2004 | B1 |
6728599 | Wang et al. | Apr 2004 | B2 |
6746443 | Morley et al. | Jun 2004 | B1 |
6766204 | Niemeyer et al. | Jul 2004 | B2 |
6770081 | Cooper et al. | Aug 2004 | B1 |
6772053 | Niemeyer | Aug 2004 | B2 |
6783524 | Anderson et al. | Aug 2004 | B2 |
6793652 | Whitman et al. | Sep 2004 | B1 |
6793653 | Sanchez et al. | Sep 2004 | B2 |
6799065 | Niemeyer | Sep 2004 | B1 |
6837883 | Moll et al. | Jan 2005 | B2 |
6839612 | Sanchez et al. | Jan 2005 | B2 |
6840938 | Morley et al. | Jan 2005 | B1 |
6843403 | Whitman | Jan 2005 | B2 |
6846309 | Whitman et al. | Jan 2005 | B2 |
6866671 | Tierney et al. | Mar 2005 | B2 |
6871117 | Wang et al. | Mar 2005 | B2 |
6879880 | Nowlin et al. | Apr 2005 | B2 |
6899705 | Niemeyer | May 2005 | B2 |
6902560 | Morley et al. | Jun 2005 | B1 |
6936042 | Wallace et al. | Aug 2005 | B2 |
6951535 | Ghodoussi et al. | Oct 2005 | B2 |
6974449 | Niemeyer | Dec 2005 | B2 |
6991627 | Madhani et al. | Jan 2006 | B2 |
6994708 | Manzo | Feb 2006 | B2 |
7048745 | Tierney et al. | May 2006 | B2 |
7066926 | Wallace et al. | Jun 2006 | B2 |
7118582 | Wang et al. | Oct 2006 | B1 |
7125403 | Julian et al. | Oct 2006 | B2 |
7155315 | Niemeyer et al. | Dec 2006 | B2 |
7239940 | Wang et al. | Jul 2007 | B2 |
7306597 | Manzo | Dec 2007 | B2 |
7357774 | Cooper | Apr 2008 | B2 |
7373219 | Nowlin et al. | May 2008 | B2 |
7379790 | Toth et al. | May 2008 | B2 |
7386365 | Nixon | Jun 2008 | B2 |
7391173 | Schena | Jun 2008 | B2 |
7398707 | Morley et al. | Jul 2008 | B2 |
7413565 | Wang et al. | Aug 2008 | B2 |
7453227 | Prisco et al. | Nov 2008 | B2 |
7524320 | Tierney et al. | Apr 2009 | B2 |
7574250 | Niemeyer | Aug 2009 | B2 |
7594912 | Cooper et al. | Sep 2009 | B2 |
7607440 | Coste-Maniere et al. | Oct 2009 | B2 |
7666191 | Orban, III et al. | Feb 2010 | B2 |
7682357 | Ghodoussi et al. | Mar 2010 | B2 |
7689320 | Prisco et al. | Mar 2010 | B2 |
7695481 | Wang et al. | Apr 2010 | B2 |
7695485 | Whitman et al. | Apr 2010 | B2 |
7699855 | Anderson et al. | Apr 2010 | B2 |
7713263 | Niemeyer | May 2010 | B2 |
7725214 | Diolaiti | May 2010 | B2 |
7727244 | Orban, III et al. | Jun 2010 | B2 |
7741802 | Prisco | Jun 2010 | B2 |
7756036 | Druke et al. | Jul 2010 | B2 |
7757028 | Druke et al. | Jul 2010 | B2 |
7762825 | Burbank et al. | Jul 2010 | B2 |
7778733 | Nowlin et al. | Aug 2010 | B2 |
7803151 | Whitman | Sep 2010 | B2 |
7806891 | Nowlin et al. | Oct 2010 | B2 |
7819859 | Prisco et al. | Oct 2010 | B2 |
7819885 | Cooper | Oct 2010 | B2 |
7824401 | Manzo et al. | Nov 2010 | B2 |
7835823 | Sillman et al. | Nov 2010 | B2 |
7843158 | Prisco | Nov 2010 | B2 |
7865266 | Moll et al. | Jan 2011 | B2 |
7865269 | Prisco et al. | Jan 2011 | B2 |
7886743 | Cooper et al. | Feb 2011 | B2 |
7899578 | Prisco et al. | Mar 2011 | B2 |
7907166 | Lamprecht et al. | Mar 2011 | B2 |
7935130 | Williams | May 2011 | B2 |
7963913 | Devengenzo et al. | Jun 2011 | B2 |
7983793 | Toth et al. | Jul 2011 | B2 |
8002767 | Sanchez | Aug 2011 | B2 |
8004229 | Nowlin et al. | Aug 2011 | B2 |
8012170 | Whitman et al. | Sep 2011 | B2 |
8054752 | Druke et al. | Nov 2011 | B2 |
8062288 | Cooper et al. | Nov 2011 | B2 |
8079950 | Stern et al. | Dec 2011 | B2 |
8100133 | Mintz et al. | Jan 2012 | B2 |
8108072 | Zhao et al. | Jan 2012 | B2 |
8120301 | Goldberg et al. | Feb 2012 | B2 |
8142447 | Cooper et al. | Mar 2012 | B2 |
8147503 | Zhao et al. | Apr 2012 | B2 |
8151661 | Schena et al. | Apr 2012 | B2 |
8155479 | Hoffman et al. | Apr 2012 | B2 |
8182469 | Anderson et al. | May 2012 | B2 |
8202278 | Orban, III et al. | Jun 2012 | B2 |
8206406 | Orban, III | Jun 2012 | B2 |
8210413 | Whitman et al. | Jul 2012 | B2 |
8216250 | Orban, III et al. | Jul 2012 | B2 |
8220468 | Cooper et al. | Jul 2012 | B2 |
8256319 | Cooper et al. | Sep 2012 | B2 |
8285517 | Sillman et al. | Oct 2012 | B2 |
8315720 | Mohr et al. | Nov 2012 | B2 |
8335590 | Costa et al. | Dec 2012 | B2 |
8347757 | Duval | Jan 2013 | B2 |
8374723 | Zhao et al. | Feb 2013 | B2 |
8418073 | Mohr et al. | Apr 2013 | B2 |
8419717 | Diolaiti et al. | Apr 2013 | B2 |
8423182 | Robinson et al. | Apr 2013 | B2 |
8452447 | Nixon | May 2013 | B2 |
8454585 | Whitman | Jun 2013 | B2 |
8499992 | Whitman et al. | Aug 2013 | B2 |
8508173 | Goldberg et al. | Aug 2013 | B2 |
8528440 | Morley et al. | Sep 2013 | B2 |
8529582 | Devengenzo et al. | Sep 2013 | B2 |
8540748 | Murphy et al. | Sep 2013 | B2 |
8551116 | Julian et al. | Oct 2013 | B2 |
8562594 | Cooper et al. | Oct 2013 | B2 |
8594841 | Zhao et al. | Nov 2013 | B2 |
8597182 | Stein et al. | Dec 2013 | B2 |
8597280 | Cooper et al. | Dec 2013 | B2 |
8600551 | Itkowitz et al. | Dec 2013 | B2 |
8608773 | Tierney et al. | Dec 2013 | B2 |
8620473 | Diolaiti et al. | Dec 2013 | B2 |
8624537 | Nowlin et al. | Jan 2014 | B2 |
8634957 | Toth et al. | Jan 2014 | B2 |
8638056 | Goldberg et al. | Jan 2014 | B2 |
8638057 | Goldberg et al. | Jan 2014 | B2 |
8644988 | Prisco et al. | Feb 2014 | B2 |
8666544 | Moll et al. | Mar 2014 | B2 |
8668638 | Donhowe et al. | Mar 2014 | B2 |
8746252 | McGrogan et al. | Jun 2014 | B2 |
8749189 | Nowlin et al. | Jun 2014 | B2 |
8749190 | Nowlin et al. | Jun 2014 | B2 |
8758352 | Cooper et al. | Jun 2014 | B2 |
8761930 | Nixon | Jun 2014 | B2 |
8768516 | Diolaiti et al. | Jul 2014 | B2 |
8786241 | Nowlin et al. | Jul 2014 | B2 |
8790243 | Cooper et al. | Jul 2014 | B2 |
8808164 | Hoffman et al. | Aug 2014 | B2 |
8816628 | Nowlin et al. | Aug 2014 | B2 |
8821480 | Burbank | Sep 2014 | B2 |
8823308 | Nowlin et al. | Sep 2014 | B2 |
8827989 | Niemeyer | Sep 2014 | B2 |
8828023 | Neff et al. | Sep 2014 | B2 |
8838270 | Druke et al. | Sep 2014 | B2 |
8852174 | Burbank | Oct 2014 | B2 |
8858547 | Brogna | Oct 2014 | B2 |
8862268 | Robinson et al. | Oct 2014 | B2 |
8864751 | Prisco et al. | Oct 2014 | B2 |
8864752 | Diolaiti et al. | Oct 2014 | B2 |
8903546 | Diolaiti et al. | Dec 2014 | B2 |
8903549 | Itkowitz et al. | Dec 2014 | B2 |
8911428 | Cooper et al. | Dec 2014 | B2 |
8912746 | Reid et al. | Dec 2014 | B2 |
8944070 | Guthart | Feb 2015 | B2 |
8989903 | Weir et al. | Mar 2015 | B2 |
9002518 | Manzo | Apr 2015 | B2 |
9014856 | Manzo et al. | Apr 2015 | B2 |
9016540 | Whitman et al. | Apr 2015 | B2 |
9019345 | O'Grady et al. | Apr 2015 | B2 |
9043027 | Durant et al. | May 2015 | B2 |
9050120 | Swarup et al. | Jun 2015 | B2 |
9055961 | Manzo et al. | Jun 2015 | B2 |
9068628 | Solomon et al. | Jun 2015 | B2 |
9078684 | Williams | Jul 2015 | B2 |
9084623 | Gomez et al. | Jul 2015 | B2 |
9095362 | Dachs, II et al. | Aug 2015 | B2 |
9096033 | Holop et al. | Aug 2015 | B2 |
9101381 | Burbank et al. | Aug 2015 | B2 |
9113877 | Whitman et al. | Aug 2015 | B1 |
9138284 | Krom et al. | Sep 2015 | B2 |
9144456 | Rosa et al. | Sep 2015 | B2 |
9198730 | Prisco et al. | Dec 2015 | B2 |
9204923 | Manzo et al. | Dec 2015 | B2 |
9226648 | Saadat et al. | Jan 2016 | B2 |
9226750 | Weir et al. | Jan 2016 | B2 |
9226761 | Burbank | Jan 2016 | B2 |
9232984 | Guthart et al. | Jan 2016 | B2 |
9241766 | Duque et al. | Jan 2016 | B2 |
9241767 | Prisco et al. | Jan 2016 | B2 |
9241769 | Larkin et al. | Jan 2016 | B2 |
9259275 | Burbank | Feb 2016 | B2 |
9259277 | Rogers et al. | Feb 2016 | B2 |
9259281 | Griffiths et al. | Feb 2016 | B2 |
9259282 | Azizian et al. | Feb 2016 | B2 |
9259290 | Jenkins | Feb 2016 | B2 |
9261172 | Solomon et al. | Feb 2016 | B2 |
9265567 | Orban, III et al. | Feb 2016 | B2 |
9265584 | Itkowitz et al. | Feb 2016 | B2 |
9283049 | Diolaiti et al. | Mar 2016 | B2 |
9301811 | Goldberg et al. | Apr 2016 | B2 |
9314307 | Richmond et al. | Apr 2016 | B2 |
9317651 | Nixon | Apr 2016 | B2 |
9345546 | Toth et al. | May 2016 | B2 |
9360934 | Ruiz Morales et al. | Jun 2016 | B2 |
9393017 | Flanagan et al. | Jul 2016 | B2 |
9402689 | Prisco et al. | Aug 2016 | B2 |
9417621 | Diolaiti | Aug 2016 | B2 |
9424303 | Hoffman et al. | Aug 2016 | B2 |
9433418 | Whitman et al. | Sep 2016 | B2 |
9446517 | Burns et al. | Sep 2016 | B2 |
9452020 | Griffiths et al. | Sep 2016 | B2 |
9474569 | Manzo et al. | Oct 2016 | B2 |
9480533 | Devengenzo et al. | Nov 2016 | B2 |
9503713 | Zhao et al. | Nov 2016 | B2 |
9550300 | Danitz et al. | Jan 2017 | B2 |
9554859 | Nowlin et al. | Jan 2017 | B2 |
9566124 | Prisco et al. | Feb 2017 | B2 |
9579164 | Itkowitz et al. | Feb 2017 | B2 |
9585641 | Cooper et al. | Mar 2017 | B2 |
9615883 | Schena et al. | Apr 2017 | B2 |
9623563 | Nixon | Apr 2017 | B2 |
9623902 | Griffiths et al. | Apr 2017 | B2 |
9629520 | Diolaiti | Apr 2017 | B2 |
9662177 | Weir et al. | May 2017 | B2 |
9664262 | Donlon et al. | May 2017 | B2 |
9687312 | Dachs, II et al. | Jun 2017 | B2 |
9700334 | Hinman et al. | Jul 2017 | B2 |
9718190 | Larkin et al. | Aug 2017 | B2 |
9730719 | Brisson et al. | Aug 2017 | B2 |
9737199 | Pistor et al. | Aug 2017 | B2 |
9795446 | DiMaio et al. | Oct 2017 | B2 |
9797484 | Solomon et al. | Oct 2017 | B2 |
9801690 | Larkin et al. | Oct 2017 | B2 |
9814530 | Weir et al. | Nov 2017 | B2 |
9814536 | Goldberg et al. | Nov 2017 | B2 |
9814537 | Itkowitz et al. | Nov 2017 | B2 |
9820823 | Richmond et al. | Nov 2017 | B2 |
9827059 | Robinson et al. | Nov 2017 | B2 |
9830371 | Hoffman et al. | Nov 2017 | B2 |
9833254 | Barral | Dec 2017 | B1 |
9839481 | Blumenkranz et al. | Dec 2017 | B2 |
9839487 | Dachs, II | Dec 2017 | B2 |
9850994 | Schena | Dec 2017 | B2 |
9855102 | Blumenkranz | Jan 2018 | B2 |
9855107 | Labonville et al. | Jan 2018 | B2 |
9872737 | Nixon | Jan 2018 | B2 |
9877718 | Weir et al. | Jan 2018 | B2 |
9883920 | Blumenkranz | Feb 2018 | B2 |
9888974 | Niemeyer | Feb 2018 | B2 |
9895813 | Blumenkranz et al. | Feb 2018 | B2 |
9901408 | Larkin | Feb 2018 | B2 |
9918800 | Itkowitz et al. | Mar 2018 | B2 |
9943375 | Blumenkranz et al. | Apr 2018 | B2 |
9948852 | Lilagan et al. | Apr 2018 | B2 |
9949798 | Weir | Apr 2018 | B2 |
9949802 | Cooper | Apr 2018 | B2 |
9952107 | Blumenkranz et al. | Apr 2018 | B2 |
9956044 | Gomez et al. | May 2018 | B2 |
9980778 | Ohline et al. | May 2018 | B2 |
10008017 | Itkowitz et al. | Jun 2018 | B2 |
10028793 | Griffiths et al. | Jul 2018 | B2 |
10033308 | Chaghajerdi et al. | Jul 2018 | B2 |
10034719 | Richmond et al. | Jul 2018 | B2 |
10052167 | Au et al. | Aug 2018 | B2 |
10085811 | Weir et al. | Oct 2018 | B2 |
10092344 | Mohr et al. | Oct 2018 | B2 |
10123844 | Nowlin | Nov 2018 | B2 |
10188471 | Brisson | Jan 2019 | B2 |
10201390 | Swarup et al. | Feb 2019 | B2 |
10213202 | Flanagan et al. | Feb 2019 | B2 |
10258416 | Mintz et al. | Apr 2019 | B2 |
10278782 | Jarc et al. | May 2019 | B2 |
10278783 | Itkowitz et al. | May 2019 | B2 |
10282881 | Itkowitz et al. | May 2019 | B2 |
10335242 | Devengenzo et al. | Jul 2019 | B2 |
10405934 | Prisco et al. | Sep 2019 | B2 |
10433922 | Itkowitz et al. | Oct 2019 | B2 |
10464219 | Robinson et al. | Nov 2019 | B2 |
10485621 | Morrissette et al. | Nov 2019 | B2 |
10500004 | Hanuschik et al. | Dec 2019 | B2 |
10500005 | Weir et al. | Dec 2019 | B2 |
10500007 | Richmond et al. | Dec 2019 | B2 |
10507066 | DiMaio et al. | Dec 2019 | B2 |
10510267 | Jarc et al. | Dec 2019 | B2 |
10524871 | Liao | Jan 2020 | B2 |
10548459 | Itkowitz et al. | Feb 2020 | B2 |
10575909 | Robinson et al. | Mar 2020 | B2 |
10592529 | Hoffman et al. | Mar 2020 | B2 |
10595946 | Nixon | Mar 2020 | B2 |
10881469 | Robinson | Jan 2021 | B2 |
10881473 | Itkowitz et al. | Jan 2021 | B2 |
10898188 | Burbank | Jan 2021 | B2 |
10898189 | McDonald, II | Jan 2021 | B2 |
10905506 | Itkowitz et al. | Feb 2021 | B2 |
10912544 | Brisson et al. | Feb 2021 | B2 |
10912619 | Jarc et al. | Feb 2021 | B2 |
10918387 | Duque et al. | Feb 2021 | B2 |
10918449 | Solomon et al. | Feb 2021 | B2 |
10932873 | Griffiths et al. | Mar 2021 | B2 |
10932877 | Devengenzo et al. | Mar 2021 | B2 |
10939969 | Swarup et al. | Mar 2021 | B2 |
10939973 | DiMaio et al. | Mar 2021 | B2 |
10952801 | Miller et al. | Mar 2021 | B2 |
10965933 | Jarc | Mar 2021 | B2 |
10966742 | Rosa et al. | Apr 2021 | B2 |
10973517 | Wixey | Apr 2021 | B2 |
10973519 | Weir et al. | Apr 2021 | B2 |
10984567 | Itkowitz et al. | Apr 2021 | B2 |
10993773 | Cooper et al. | May 2021 | B2 |
10993775 | Cooper et al. | May 2021 | B2 |
11000331 | Krom et al. | May 2021 | B2 |
11013567 | Wu et al. | May 2021 | B2 |
11020138 | Ragosta | Jun 2021 | B2 |
11020191 | Diolaiti et al. | Jun 2021 | B2 |
11020193 | Wixey et al. | Jun 2021 | B2 |
11026755 | Weir et al. | Jun 2021 | B2 |
11026759 | Donlon et al. | Jun 2021 | B2 |
11040189 | Vaders et al. | Jun 2021 | B2 |
11045077 | Stern et al. | Jun 2021 | B2 |
11045274 | Dachs, II et al. | Jun 2021 | B2 |
11058501 | Tokarchuk et al. | Jul 2021 | B2 |
11076925 | DiMaio et al. | Aug 2021 | B2 |
11090119 | Burbank | Aug 2021 | B2 |
11096687 | Flanagan et al. | Aug 2021 | B2 |
11098803 | Duque et al. | Aug 2021 | B2 |
11109925 | Cooper et al. | Sep 2021 | B2 |
11116578 | Hoffman et al. | Sep 2021 | B2 |
11129683 | Steger et al. | Sep 2021 | B2 |
11135029 | Suresh et al. | Oct 2021 | B2 |
11147552 | Burbank et al. | Oct 2021 | B2 |
11147640 | Jarc et al. | Oct 2021 | B2 |
11154373 | Abbott et al. | Oct 2021 | B2 |
11154374 | Hanuschik et al. | Oct 2021 | B2 |
11160622 | Goldberg et al. | Nov 2021 | B2 |
11160625 | Wixey et al. | Nov 2021 | B2 |
11161243 | Rabindran et al. | Nov 2021 | B2 |
11166758 | Mohr et al. | Nov 2021 | B2 |
11166770 | DiMaio et al. | Nov 2021 | B2 |
11166773 | Ragosta et al. | Nov 2021 | B2 |
11173597 | Rabindran et al. | Nov 2021 | B2 |
11185378 | Weir et al. | Nov 2021 | B2 |
11191596 | Thompson et al. | Dec 2021 | B2 |
11197729 | Thompson et al. | Dec 2021 | B2 |
11213360 | Hourtash et al. | Jan 2022 | B2 |
11221863 | Azizian et al. | Jan 2022 | B2 |
11234700 | Ragosta et al. | Feb 2022 | B2 |
11241274 | Vaders et al. | Feb 2022 | B2 |
11241290 | Waterbury et al. | Feb 2022 | B2 |
11259870 | DiMaio et al. | Mar 2022 | B2 |
11259884 | Burbank | Mar 2022 | B2 |
11272993 | Gomez et al. | Mar 2022 | B2 |
11272994 | Saraliev et al. | Mar 2022 | B2 |
11291442 | Wixey et al. | Apr 2022 | B2 |
11291513 | Manzo et al. | Apr 2022 | B2 |
11744667 | Shelton, IV | Sep 2023 | B2 |
20100228249 | Mohr et al. | Sep 2010 | A1 |
20100312095 | Jenkins et al. | Dec 2010 | A1 |
20130030571 | Ruiz Morales et al. | Jan 2013 | A1 |
20130169423 | Iorgulescu et al. | Jul 2013 | A1 |
20140005684 | Kim et al. | Jan 2014 | A1 |
20140323803 | Hoffman et al. | Oct 2014 | A1 |
20160008078 | Azizian | Jan 2016 | A1 |
20160338782 | Bowling et al. | Nov 2016 | A1 |
20160354166 | Popovic et al. | Dec 2016 | A1 |
20170000574 | Itkowitz et al. | Jan 2017 | A1 |
20170172382 | Nir et al. | Jun 2017 | A1 |
20170339399 | Hoffman et al. | Nov 2017 | A1 |
20190223759 | Page | Jul 2019 | A1 |
20200015925 | Scheib | Jan 2020 | A1 |
20200289219 | Denlinger | Sep 2020 | A1 |
20200289222 | Denlinger | Sep 2020 | A1 |
20210196384 | Shelton, IV | Jul 2021 | A1 |
20210196424 | Shelton, IV | Jul 2021 | A1 |
20230248432 | McLoughlin | Aug 2023 | A1 |
Number | Date | Country |
---|---|---|
104582624 | Apr 2015 | CN |
2015527906 | Sep 2015 | JP |
2016187290 | Nov 2016 | WO |
2019139944 | Jul 2019 | WO |
Entry |
---|
Partial Supplementary European Search Report dated Sep. 7, 2021 corresponding to counterpart Patent Application EP 19738088.4. |
First Examination Report issued in corresponding application IN202017029105 dated Apr. 27, 2022 (5 pages). |
Japanese Office Action dated Feb. 24, 2023, issued in corresponding JP Appln. No. 2020538102, 5 pages. |
International Search Report mailed May 2, 2019 and Written Opinion completed May 1, 2019 corresponding to counterpart Int'l Patent Application PCT/US2019/012847. |
U.S. Appl. No. 62/615,578, filed Jan. 10, 2018, entitled “Surgical Robotic Arms and Pulley Assemblies Thereof”. |
Chinese Office Action dated Jul. 22, 2023 issued in Chinese Patent Application No. 201980007882.5 (18 pages). |
Extended European Search Report dated Nov. 30, 2021 corresponding to counterpart Patent Application EP 19738088.4. |
Number | Date | Country | |
---|---|---|---|
20210059775 A1 | Mar 2021 | US |
Number | Date | Country | |
---|---|---|---|
62615590 | Jan 2018 | US |